MYP_127895
Basic Information
FSEC
Anticancer
Antimicrobial
Toxicity / Safety Blood cell toxicity Hemolysis Hemolytic
Toxicity / Safety Cytotoxicity Cytotoxic
Wound healing/Regeneration Angiogenesis modulation Anti-angiogenic
Standard
11 amino acids
C48H77N13O21S3
Standard
Sequence
CELDENNTPMC
Physicochemical Analysis
1268.39 Da
4.05
-3.25
-3.49
-0.2957
-0.83
0.13
-0.14
-5.48
35.45
0.0000
0.00
125.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
563.84
-7.25
19.0
21.0
40.0
85.0
1.0
12.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0423727 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
SPARC-derived peptide
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
1-11
Bio-Activity Profile
Antiangiogenic Antitumor Anticancer
HUVEC; bFGF-stimulated endothelial-cell migration
~1 pM
EC50 (bFGF-stimulated HUVEC migration assay)
Showing 1 records · Page 2 of 2